Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Keros Therapeutics stock has a consensus rating of "Buy" and an average price target of $21.83. The average 1-year stock price forecast is 100.92% higher than the current stock price, while the lowest is $16 (+47.26%) and the highest is $30 (+176.12%).

Price Target: $21.83 (+100.92%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$16	$21.83	$20	$30
Change	+47.26%	+100.92%	+84.08%	+176.12%

Analyst Ratings

The average analyst rating for Keros Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	May '26
Strong Buy	6	6	6	5	5	3
Buy	0	0	0	0	0	0
Hold	5	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	10	10	9	9	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yun Zhong Wedbush	Wedbush	Hold Maintains $16	Hold	Maintains	$16	+47.26%	May 19, 2026
Srikripa Devarakonda Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 15, 2026
Nicholas Lorusso TD Cowen	TD Cowen	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 15, 2026
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Maintains $20	Buy	Maintains	$20	+84.08%	May 15, 2026
Andres Y. Maldonado H.C. Wainwright	H.C. Wainwright	Buy Reiterates $20	Buy	Reiterates	$20	+84.08%	May 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

3.02M

Decreased by -98.76%

from 244.06M

Revenue Next Year

9.69M

Increased by 221.33%

from 3.02M

EPS This Year

-5.89

from 2.30

EPS Next Year

-5.89

from -5.89

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	20.10M	-	151.00K	3.55M	244.06M	3.02M	9.69M
Revenue Growth	-	-	-	2,250.99%	6,774.96%	-98.76%	221.33%
EPS	-2.52	-4.15	-5.20	-5.00	2.30	-5.89	-5.89
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	10.5M	52.5M
Avg	3.0M	9.7M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-95.7%	1,641.3%
Avg	-98.8%	221.3%
Low	-	-

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	-3.84	-3.84
Avg	-5.89	-5.89
Low	-7.93	-8.43

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.